Functional analysis of glycosylation in Etanercept: Effects over potency and stability

被引:4
作者
Medina Martinez, Victor Perez [1 ]
Tierrablanca-Sanchez, Lilia [1 ]
Espinosa-de la Garza, Carlos E. [1 ]
Juarez-Bayardo, Laura C. [1 ]
Pina-Lara, Nelly [1 ]
Gonzalez Santoyo, German [2 ]
Perez, Nestor O. [1 ]
机构
[1] Probiomed SA CV, Unidad Invest & Desarrollo, Tenancingo 52400, Estado De Mexic, Mexico
[2] Probiomed SA CV, Direcc Med, Cd De Mexico 11520, Mexico
关键词
Etanercept; Deglycosylation; Tumor necrosis factor; Sialic acids; N-GLYCOSYLATION; IGG; MECHANISMS; ORIGINATOR; OXIDATION; SELECTION; GLYCANS; IMPACT; AGENTS;
D O I
10.1016/j.ejps.2020.105467
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Etanercept is a biotechnological product that has a complex glycosylation profile. To elucidate Etanercept glycosylation effect over biological activity and stability, we deglycosylated sequentially this molecule. Sequential deglycosylation was performed to understand which glycans are critical for Etanercept folding and activity. Extended study showed that gross glycosylation differences, affect thermal stability, hydrodynamic radius, pI, CDC, ADCC, protection against oxidation and charge surface exposition with any effect (within biological assay dispersion) over TNF alpha neutralization, indicating which glycoforms have a critical effect over Etanercept ADCC, CDC and stability. In this regard, complete remotion of sialic acids have a predominant importance over pI, ADCC, CDC and surface charge while N and O glycosylation over thermal stability, hydrophobicity, aggregation and protection against oxidation. Our research suggest that gross differences in the glycosylation profile are relevant for the stability and biological main activities of Etanercept, and that significant differences that affect the activities related to this fusion protein could be detected with proper analytical methods and stability studies.
引用
收藏
页数:15
相关论文
共 58 条
[1]   FORMATION OF DITYROSINE CROSS-LINKS IN PROTEINS BY OXIDATION OF TYROSINE RESIDUES [J].
AESCHBACH, R ;
AMADO, R ;
NEUKOM, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 439 (02) :292-301
[2]   Sialyltransferase-Based Chemoenzymatic Histology for the Detection of N- and O-Glycans [J].
Aguilar, Aime Lopez ;
Meng, Lu ;
Hou, Xiaomeng ;
Li, Wei ;
Moremen, Kelley W. ;
Wu, Peng .
BIOCONJUGATE CHEMISTRY, 2018, 29 (04) :1231-1239
[3]   Increased serum clearance of oligomannose species present on a human IgG1 molecule [J].
Alessandri, Leslie ;
Ouellette, David ;
Acquah, Aima ;
Rieser, Mathew ;
LeBlond, David ;
Saltarelli, Mary ;
Radziejewski, Czeslaw ;
Fujimori, Taro ;
Correia, Ivan .
MABS, 2012, 4 (04) :509-520
[4]   Physical Stability Comparisons of IgG1-Fc Variants: Effects of N-Glycosylation Site Occupancy and Asp/Gln Residues at Site Asn 297 [J].
Alsenaidy, Mohammad A. ;
Okbazghi, Solomon Z. ;
Kim, Jae Hyun ;
Joshi, Sangeeta B. ;
Middaugh, C. Russell ;
Tolbert, Thomas J. ;
Volkin, David B. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (06) :1613-1627
[5]   CARBOHYDRATE-SPECIFIC RECEPTORS OF THE LIVER [J].
ASHWELL, G ;
HARFORD, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 :531-554
[6]  
Beutler B.A., 1992, Patent, Patent No. 5447851B1
[7]   Glycosimilarity assessment of biotherapeutics 1: Quantitative comparison of the N-glycosylation of the innovator and a biosimilar version of etanercept [J].
Borza, Beata ;
Szigeti, Marton ;
Szekrenyes, Akos ;
Hajba, Laszlo ;
Guttman, Andras .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 153 :182-185
[8]   Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept [J].
Cho, Ick Hyun ;
Lee, Nayoung ;
Song, Dami ;
Jung, Seong Young ;
Bou-Assaf, George ;
Sosic, Zoran ;
Zhang, Wei ;
Lyubarskaya, Yelena .
MABS, 2016, 8 (06) :1136-1155
[9]   Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcy receptor binding and antibody-dependent cell-mediated cytotoxicity activities [J].
Chung, Shan ;
Quarmby, Valerie ;
Gao, Xiaoying ;
Ying, Yong ;
Lin, Linda ;
Reed, Chae ;
Fong, Chris ;
Lau, Wendy ;
Qiu, Zhihua J. ;
Shen, Amy ;
Vanderlaan, Martin ;
Song, An .
MABS, 2012, 4 (03) :326-340
[10]   Differentiating factors between erythropoiesis-stimulating agents -: A guide to selection for anaemia of chronic kidney disease [J].
Deicher, R ;
Hörl, WH .
DRUGS, 2004, 64 (05) :499-509